What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Alzheimer's disease
- Disease
Harald Hampel mostly deals with Alzheimer's disease, Disease, Dementia, Pathology and Biomarker.
The concepts of his Alzheimer's disease study are interwoven with issues in Genome-wide association study, Central nervous system disease and Immunology.
His Genome-wide association study research includes themes of Apolipoprotein E and Genetic association.
His work deals with themes such as Clinical trial, Bioinformatics and Intensive care medicine, which intersect with Disease.
His Dementia research integrates issues from Neurology, Neuroimaging, Neuroscience and Cohort study.
His Biomarker research includes elements of Psychiatry and Position paper.
His most cited work include:
- Inflammation and Alzheimer's disease. (3451 citations)
- Mild cognitive impairment (2753 citations)
- Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease (2614 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of investigation include Disease, Internal medicine, Dementia, Neuroscience and Alzheimer's disease.
In his study, Intensive care medicine and Biomarker discovery is strongly linked to Biomarker, which falls under the umbrella field of Disease.
The various areas that Harald Hampel examines in his Internal medicine study include Gastroenterology, Endocrinology and Oncology.
His Dementia study combines topics in areas such as Psychiatry and Neurology.
His research integrates issues of Diffusion MRI and Neurodegeneration in his study of Neuroscience.
His work carried out in the field of Alzheimer's disease brings together such families of science as Genetics and Central nervous system disease, Degenerative disease.
He most often published in these fields:
- Disease (53.82%)
- Internal medicine (33.84%)
- Dementia (35.14%)
What were the highlights of his more recent work (between 2015-2021)?
- Disease (53.82%)
- Internal medicine (33.84%)
- Neuroscience (31.02%)
In recent papers he was focusing on the following fields of study:
Harald Hampel mainly investigates Disease, Internal medicine, Neuroscience, Dementia and Biomarker.
His research in Disease is mostly concerned with Alzheimer's disease.
His Alzheimer's disease research is multidisciplinary, relying on both Genetics and Resting state fMRI.
His Internal medicine course of study focuses on Endocrinology and Atrophy.
His studies deal with areas such as Neurodegeneration and Amyloid as well as Neuroscience.
Harald Hampel has researched Dementia in several fields, including Psychological intervention, Psychiatry, Cerebrospinal fluid and Pathophysiology.
Between 2015 and 2021, his most popular works were:
- Analysis of shared heritability in common disorders of the brain (726 citations)
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. (663 citations)
- Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria. (663 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Alzheimer's disease
Disease, Dementia, Alzheimer's disease, Biomarker and Internal medicine are his primary areas of study.
His Disease study incorporates themes from Precision medicine and Neurology, Neuroscience.
The study incorporates disciplines such as Magnetic resonance imaging, Pathophysiology, Psychiatry and Cerebrospinal fluid in addition to Dementia.
The Alzheimer's disease study combines topics in areas such as Genetics, Bioinformatics, Linkage disequilibrium, Allele frequency and Blood based biomarkers.
As a part of the same scientific study, Harald Hampel usually deals with the Biomarker, concentrating on Intensive care medicine and frequently concerns with Paradigm shift.
His research in Internal medicine intersects with topics in Endocrinology, Oncology and Geriatrics.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
